HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
about
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
description
clinical trial
@en
klinisch onderzoek
@nl
name
HER2-specific CAR T Cell Locor ...... efractory Pediatric CNS Tumors
@en
type
label
HER2-specific CAR T Cell Locor ...... efractory Pediatric CNS Tumors
@en
prefLabel
HER2-specific CAR T Cell Locor ...... efractory Pediatric CNS Tumors
@en
P1050
P1476
Phase 1 Study of HER2-Specific ...... Central Nervous System Tumors
@en
P3098
NCT03500991
P580
2018-07-26T00:00:00Z
P582
2021-07-26T00:00:00Z